A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2002
12/12/2002	US20020188000 Imidazo-pyridine derivatives as ligands for gaba receptors
12/12/2002	US20020187982 Glucagon antagonists/inverse agonists
12/12/2002	US20020187978 4-Heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
12/12/2002	US20020187973 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187970 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
12/12/2002	US20020187969 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187968 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
12/12/2002	US20020187967 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187966 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187965 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187964 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187963 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187962 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187943 Bioavailable composition of natural and synthetic hca
12/12/2002	US20020187939 Use of inhibitors of the renin-angiotensin system
12/12/2002	US20020187247 Branched maltodextrins having between 15 and 35% of 1-6 glucoside linkages, a reducing sugar content of less than 20%, a polymolecularity index of less than 5
12/12/2002	US20020187219 A) one or more flavanols; b) one or more bracers such as caffeine; and c) vitamin B
12/12/2002	US20020187201 Process for the cure and control of diabetes mellitus using natural products from perna viridis
12/12/2002	US20020187197 Templating of solid particles by polymer multilayers
12/12/2002	US20020187121 Administering an amine polymer, such as a polyethylenimine salt or an epichlorohydrin crosslinked polyallylamine
12/12/2002	US20020187120 Method for treating gout and reducing serum uric acid
12/12/2002	DE10125883A1 Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie Medicines containing an effector of the glutathione metabolism together with alpha-lipoic acid in the context of renal replacement therapy
12/12/2002	DE10125882A1 Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Behandlung des Diabetes mellitus Medicines containing an effector of the glutathione metabolism together with alpha-lipoic acid in the treatment of diabetes mellitus
12/12/2002	CA2449813A1 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002	CA2449426A1 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002	CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	CA2449097A1 5-ethyl-imidazotriazinones
12/12/2002	CA2449024A1 Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
12/12/2002	CA2448861A1 Methods and formulations for enhancing the dissolution of a solid material in liquid
12/12/2002	CA2448606A1 Nucleic acid-associated proteins
12/12/2002	CA2448382A1 Use of hepcidin as a regulator of iron homeostasis
12/12/2002	CA2448379A1 Calorically dense liquid oral supplement
12/12/2002	CA2448044A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof
12/12/2002	CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
12/12/2002	CA2446696A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/11/2002	EP1264844A1 Modified bdnf
12/11/2002	EP1264837A1 Conjugation-stabilized polypeptide compositions
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264599A1 TNF-derived peptides for use in treating oedema
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1263959A1 Antibodies to human cd154
12/11/2002	EP1263958A2 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
12/11/2002	EP1263786A2 Methods and compositions for immunoregulation
12/11/2002	EP1263761A2 Compounds for pdt
12/11/2002	EP1263760A1 Novel compounds
12/11/2002	EP1263759A2 Azaindoles
12/11/2002	EP1263757A1 Benzthiazoles as tnf and pde-iv inhibitors
12/11/2002	EP1263747A1 1,5-benzothiazepines and their use as hypolipidaemics
12/11/2002	EP1263746A1 Substituted 8, 8a-dihydro-3ah-indeno 1,2-d]thiazoles, a method for their production and their use as medicaments
12/11/2002	EP1263745A1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase
12/11/2002	EP1263740A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
12/11/2002	EP1263739A1 Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid
12/11/2002	EP1263733A2 Derivatives of quinoline as alpha-2 antagonists
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263729A1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/11/2002	EP1263725A1 Novel compounds
12/11/2002	EP1263724A1 Novel compounds
12/11/2002	EP1263722A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
12/11/2002	EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
12/11/2002	EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
12/11/2002	EP1263718A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1263470A1 METHOD FOR PRODUCING A COENZYME Q10 / $g(g)-CYCLODEXTRIN COMPLEX
12/11/2002	EP1263469A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues
12/11/2002	EP1263466A1 Methods and compositions for dietary supplements
12/11/2002	EP1263464A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function
12/11/2002	EP1263458A1 Lowering serum lipids
12/11/2002	EP1263433A2 Glycogen phosphorylase inhibitor
12/11/2002	EP1263418A2 Cartilage enhancing food supplements and methods of preparing the same
12/11/2002	EP1263414A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors
12/11/2002	EP1263297A1 Diabetic nutritionals
12/11/2002	EP1071433B1 2',2'-difluoronucleosides for immunosuppressive therapy and combined pharmaceutical compositions
12/11/2002	EP1017378B1 Amide derivatives for the treatment of diseases mediated by cytokines
12/11/2002	EP0942741B1 Lectin compositions and uses thereof
12/11/2002	EP0837854B1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
12/11/2002	EP0807185B9 Antitumor preparations containing a lipoteichoic acid from steptococcus
12/11/2002	EP0805796B1 Cell adhesion inhibitors
12/11/2002	CN1385036A Communications system
12/11/2002	CN1384835A Tricycle inhibitors of poly(ADP-ribose) polymerases
12/11/2002	CN1384833A Synthesis and methods of use of 9-substituted guanine derivatives
12/11/2002	CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
12/11/2002	CN1384829A Sodium-hydrogen exchanger type 1 inhibitor crystals
12/11/2002	CN1384827A Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
12/11/2002	CN1384825A Benzylidene thiazolidiones and analogues and their use in treatment of inflammation
12/11/2002	CN1384821A Method for improving solubility of tricyclic amino alcohol derivatives
12/11/2002	CN1384816A Polymorphic forms of sertraline hydrochloride
12/11/2002	CN1384814A Phenoxy carboxylic acid compounds and compositions for delivering active agents
12/11/2002	CN1384756A Pharmaceutical formulations and use thereof in prevention of stroke, diabetes and/or congestive heart failure
12/11/2002	CN1384755A Novel exendin agonist formulations and methods administration thereof
12/11/2002	CN1384747A Use of 2-amino-3,4-dihydro-quinazolines for producing medicament for treating or preventing diseases caused by ischaemic conditions
12/11/2002	CN1384742A Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia
12/11/2002	CN1384733A Dry powder compositions having improved dispersivity
12/11/2002	CN1384201A Blood sugar reducing method of orally taking human insulin-like growth factor-I produced in silkworm bioreactor
12/11/2002	CN1383890A Medicine for treating complication of diabetes and its production process
12/11/2002	CN1383848A Specific medicine for treating diabetes
12/11/2002	CN1383833A 鳄鱼钙 Crocodile calcium
12/11/2002	CN1383743A Blood fat-reducing slimming noodles
12/11/2002	CN1383742A Health food of blood fat-regulating and intelligence growth-promoting peptide
12/11/2002	CN1095841C 化合物 Compound
12/11/2002	CN1095676C Health food capable of lowering blood lipoid, resisting senility and regulating immunity
12/11/2002	CN1095671C Blood sugar reducing agent containing powder of silkworm as effective ingredient and its making method

1 ... 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 ... 1298